The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome.

Mullan, Karen R

The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome. [electronic resource] - Clinical endocrinology May 2006 - 519-22 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0300-0664

10.1111/j.1365-2265.2006.02501.x doi


Adrenalectomy
Adrenocorticotropic Hormone--blood
Adult
Drug Administration Schedule
Humans
Middle Aged
Nelson Syndrome--blood
PPAR gamma--metabolism
Pituitary ACTH Hypersecretion--metabolism
Rosiglitazone
Statistics, Nonparametric
Thiazolidinediones--therapeutic use
Time Factors
Treatment Failure